OCT1 Expression in Adipocytes Could Contribute to Increased Metformin Action in Obese Subjects
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Metformin has been well characterized in vitro as a substrate of liver-expressed organic cation transporters (OCTs). We investigated the gene expression and protein levels of OCT-1 and OCT-2 in adipose tissue and during adipogenesis and evaluated their possible role in metformin action on adipocytes. RESEARCH DESIGN AND METHODS: OCT1 and OCT2 gene expressions were analyzed in 118 adipose tissue samples (57 visceral and 61 subcutaneous depots) and during human preadipocyte differentiation. To test the possible role of OCT1 mediating the response of adipocytes to metformin, cotreatments with cimetidine (OCT blocker, 0.5 and 5 mmol/l) and metformin were made on human preadipocytes and subcutaneous adipose tissue (SAT). RESULTS: OCT1 gene was expressed in both subcutaneous and visceral adipose tissue. In both fat depots, OCT1 gene expression and protein levels were significantly increased in obese subjects. OCT1 gene expression in isolated preadipocytes significantly increased during differentiation in parallel to adipogenic genes. Metformin (5 mmol/l) decreased the expression of lipogenic genes and lipid droplets accumulation while increasing AMP-activated protein kinase (AMPK) activation, preventing differentiation of human preadipocytes. Cotreatment with cimetidine restored adipogenesis. Furthermore, metformin decreased IL-6 and MCP-1 gene expression in comparison with differentiated adipocytes. Metformin (0.1 and 1 mmol/l) decreased adipogenic and inflammatory genes in SAT. OCT2 gene expression was not detected in adipose tissue and was very small in isolated preadipocytes, disappearing during adipogenesis. CONCLUSIONS: OCT1 gene expression and protein levels are detectable in adipose tissue. Increased OCT1 gene expression in adipose tissue of obese subjects might contribute to increased metformin action in these subjects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The hepatic, intestinal and adipocytic uptake of metformin is primarily mediated through the OCT1”
From Benefits of Metformin in Attenuating the Hallmarks of Aging (2020) · cites this paper as Moreno-Navarrete et al. 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
An, Z., Wang, H., Song, P., Zhang, M., Geng, X., & Zou, M.-H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703701200 · Cited by 98
RetractedReduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 3×
“Metformin has been described to be more effective in obese subjects, and the degree of obesity has been found to constitute a strong predictor of metformin effects (3,4).”
BackgroundOWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157 · cited 1×
“It has been reported that metformin binds to complex I of the mitochondrial respiratory chain, and this could in part explain how this drug acts (20).”
BackgroundBailey, C. J., & Turner, R. C. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602293340906 · Cited by 1,726
Kirpichnikov, D., McFarlane, S. I., & Sowers, J. R. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00009 · Cited by 1,084 · cited 1×
“Metformin (dimethylbiguanidine) is the most widely used drug for the treatment of type 2 diabetes (1,2).”
BackgroundKoepsell, H., Lips, K., & Volk, C. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9254-z · Cited by 988
Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action
Shu, Y., Sheardown, S. A., Brown, C., Owen, R. P., Zhang, S., Castro, R. A., Ianculescu, A. G., Yue, L., Lo, J. C., Burchard, E. G., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30558 · Cited by 967 · cited 2×
“OCT1 has been reported to be necessary for metabolic activities of metformin in liver cell lines (10).”
BackgroundAMP-Activated Protein Kinase – Development of the Energy Sensor Concept
Hardie, D. G., Hawley, S. A., & Scott, J. W. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.108944 · Cited by 813 · cited 1×
“The activated form of AMPK switches on catabolic pathways while switching off ATP-consuming processes (19).”
BackgroundMetformin Inhibits Proinflammatory Responses and Nuclear Factor-κB in Human Vascular Wall Cells
Isoda, K., Young, J. L., Zirlik, A., MacFarlane, L. A., Tsuboi, N., Gerdes, N., Schönbeck, U., & Libby, P. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000201938.78044.75 · Cited by 499
Effect of Genetic Variation in the Organic Cation Transporter 1, OCT1, on Metformin Pharmacokinetics
Shu, Y., Brown, C., Castro, R., Shi, R., Lin, E., Owen, R., Sheardown, S., Yue, L., Burchard, E., Brett, C., et al. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100275 · Cited by 477 · cited 1×
“Subjects carrying a single nucleotid polymorphism associated with a decrease in OCT1 gene expression also showed decreased metformin effects (4,10,16).”
BackgroundInvolvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin
Wang, D.-S., Jonker, J. W., Kato, Y., Kusuhara, H., Schinkel, A. H., & Sugiyama, Y. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.034140 · Cited by 441 · cited 1×
“Considering the importance of OCT1 in the metformin response (9), we suggest that the higher OCT1 gene expression in obese subjects is behind the increased metformin effects in these subjects.”
BackgroundCloning and Functional Expression of a Human Liver Organic Cation Transporter
Zhang, L., Dresser, M. J., Gray, A. T., Yost, S. C., Terashita, S., & Giacomini, K. M. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.6.913 · Cited by 417
Dresser, M. J., Leabman, M. K., & Giacomini, K. M. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200104)90:4<397::aid-jps1000>3.0.co;2-d · Cited by 290 · cited 1×
“In addition to the liver-specific OCT1, its paralog, human solute carrier family 22 (organic cation transporter), member 2 (OCT2) is a transporter expressed in abundance in the kidney (7,8).”
BackgroundPrediction of adipose tissue: Plasma partition coefficients for structurally unrelated drugs
Poulin, P., Schoenlein, K., & Theil, F. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200104)90:4<436::aid-jps1002>3.0.co;2-p · Cited by 213
Shikata, E., Yamamoto, R., Takane, H., Shigemasa, C., Ikeda, T., Otsubo, K., & Ieiri, I. (2007) · Journal of Human Genetics · doi:10.1007/s10038-006-0087-0 · Cited by 207 · cited 3×
“Metformin has been described to be more effective in obese subjects, and the degree of obesity has been found to constitute a strong predictor of metformin effects (3,4).”
BackgroundHuang, N.-L., Chiang, S.-H., Hsueh, C.-H., Liang, Y.-J., Chen, Y.-J., & Lai, L.-P. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.04.010 · Cited by 159
Effects of troglitazone and metformin on glucose and lipid metabolism
Lenhard, J. M., Kliewer, S. A., Paulik, M. A., Plunket, K. D., Lehmann, J. M., & Weiel, J. E. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00229-3 · Cited by 111
Dresser, M. J., Xiao, G., Leabman, M. K., Gray, A. T., & Giacomini, K. M. (2002) · Pharmaceutical Research · doi:10.1023/a:1019870831174 · Cited by 92 · cited 1×
“In addition to the liver-specific OCT1, its paralog, human solute carrier family 22 (organic cation transporter), member 2 (OCT2) is a transporter expressed in abundance in the kidney (7,8).”
BackgroundHuypens, P., Quartier, E., PIPELEERS, D. G., & de Casteele, M. V. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.06.016 · Cited by 85
Metformin regulates osteoblast and adipocyte differentiation of rat mesenchymal stem cells
Gao, Y., Xue, J., Li, X., Jia, Y., & Hu, J. (2008) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.60/12.0017 · Cited by 76
Fernández-Real, J. M., Moreno, J. M., & Ricart, W. (2008) · Diabetes · doi:10.2337/db08-0041 · Cited by 45
Self-citationMetformin inhibits intracellular lipid accumulation in the murine pre‐adipocyte cell line, 3T3‐L1
Alexandre, K. B., Smit, A. M., Gray, I. P., & Crowther, N. J. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00890.x · Cited by 42
Metformin induces glucose uptake in human preadipocyte‐derived adipocytes from various fat depots
Fischer, M., Timper, K., Radimerski, T., Dembinski, K., Frey, D. M., Zulewski, H., Keller, U. B., Müller-Stich, B. P., Christ‐Crain, M., & Grisouard, J. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01169.x · Cited by 35 · cited 2×
“(14) have shown that metformin induces glucose uptake independent of insulin in subcutaneous and visceral human adipocytes.”
Background
Cited by
Moreno-Navarrete, J. M., Ortega, F., Serrano, M., Guerra, E., Pardo, G., Tinahones, F., Ricart, W., & Fernández-Real, J. M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2749 · Cited by 788
“Human adipocyte differentiation Subcutaneous human preadipocytes (Zen-Bio Inc, Research Triangle Park, North Carolina) were cultured and differentiated as previously described (16).”
Self-citationBenefits of Metformin in Attenuating the Hallmarks of Aging
Kulkarni, A. S., Gubbi, S., & Barzilai, N. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.04.001 · Cited by 766
The SLC22 family with transporters of organic cations, anions and zwitterions
Koepsell, H. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.10.010 · Cited by 388
“…mammary gland, adrenal gland, eye, adipose tissue, and immune cells (Gilchrist and Alcorn, 2010; Koepsell et al., 2007; Minuesa et al., 2008; Moreno-Navarrete et al., 2011; Nishimura and Naito, 2005; Zhang et al., 2008b), and in various tumors (Gupta et al., 2011; Koepsell et al., 2007;…”
BackgroundDrug Transporters in Drug Efficacy and Toxicity
DeGorter, M. K., Xia, C. Q., Yang, J. J., & Kim, R. B. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134529 · Cited by 359
“In humans, OCT1, but not OCT2, expression was observed in subcutaneous and visceral adipose tissue, and OCT1 expression was increased in samples from obese subjects, suggesting that metformin action in these tissues may account for better metformin response in obese individuals (27).”
BackgroundOrganic Cation Transporters in Health and Disease
Koepsell, H. (2020) · Pharmacological Reviews · doi:10.1124/pr.118.015578 · Cited by 297
Metadata
- Authors
- Moreno-Navarrete, J. M., Ortega, F. J., Rodríguez-Hermosa, J.-I., Sabater, M., Pardo, G., Ricart, W., & Fernández-Real, J. M.
- Affiliations
- From the Department of Diabetes, Endocrinology and Nutrition, Institut d'Investigació Biomédica de Girona, CIBER Fisiopatología de la Obesidad y Nutrición CB06/03/010, Girona. Spain.
- Institut d'Investigació Biomèdica de Girona (ES)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2010-10-18
- Volume
- 60
- Issue
- 1
- Pages
- 168-176
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3012168
- OpenAlex
- W2137586574
- Cited by
- 100
- References
- 22
- Citations by year
- 2025: 4 · 2024: 5 · 2023: 6 · 2022: 5 · 2021: 2 · 2020: 4 · 2019: 9 · 2018: 12 · 2017: 3 · 2016: 9 · 2015: 8 · 2014: 9 · 2013: 9 · 2012: 5
- FWCI
- 3.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- OCT1, organic cation transporters, metformin, adipocytes, adipose tissue, obesity, adipogenesis, preadipocyte differentiation, cimetidine, AMPK, lipogenesis, visceral adipose tissue, subcutaneous adipose tissue, interleukin-6, MCP-1, inflammation, drug transport
- MeSH terms
- Organic Cation Transporter 2, Acetyl-CoA Carboxylase, Acetyltransferases, Adenylate Kinase, Azo Compounds, Cell Differentiation, Coloring Agents, Gene Expression Regulation, Humans, Hypoglycemic Agents, Metformin, Obesity, RNA, Gastric Bypass, Gene Expression, Adipocytes, Organic Cation Transport Proteins, Organic Cation Transporter 1, PPAR gamma, Fatty Acid Synthase, Type I
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.